LYEL Financial Statements

Balance sheet, income statement, cash flow, and dividends for Lyell Immunopharma Inc (LYEL).


$178.70M Market Cap.

As of 03/11/2025 5:00 PM ET (MRY) • Disclaimer

LYEL Market Cap. (MRY)


LYEL Shares Outstanding (MRY)


LYEL Assets (MRY)


Total Assets

$490.86M

Total Liabilities

$108.03M

Total Investments

$296.94M

LYEL Income (MRY)


Revenue

$61.00K

Net Income

-$342.99M

Operating Expense

$358.82M

LYEL Cash Flow (MRY)


CF Operations

-$162.39M

CF Investing

$122.42M

CF Financing

$1.33M

LYEL Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

LYEL Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$490,859,000 (-34.55%)

$750,029,000 (-20.00%)

$937,561,000 (-16.84%)

$1,127,406,000 (24.13%)

Assets Current

$379,594,000 (-31.57%)

$554,686,000 (-14.83%)

$651,295,000 (3.99%)

$626,286,000 (1.42%)

Assets Non-Current

$111,265,000 (-43.04%)

$195,343,000 (-31.76%)

$286,266,000 (-42.87%)

$501,120,000 (72.36%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$382,824,000 (-41.55%)

$654,952,000 (-21.40%)

$833,252,000 (-10.38%)

$929,787,000 (417.85%)

Property Plant & Equipment Net

$72,939,000 (-48.75%)

$142,317,000 (-14.40%)

$166,265,000 (-0.22%)

$166,639,000 (34.33%)

Cash & Equivalents

$107,287,000 (-26.48%)

$145,931,000 (17.84%)

$123,834,000 (-57.92%)

$294,294,000 (108.91%)

Accumulated Other Comprehensive Income

$291,000 (409.57%)

-$94,000 (98.76%)

-$7,599,000 (-368.21%)

-$1,623,000 (-733.98%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$84,653,000 (-11.04%)

Total Investments

$296,944,000 (-33.88%)

$449,083,000 (-28.90%)

$631,639,000 (-3.05%)

$651,498,000 (2.49%)

Investments Current

$264,930,000 (-33.86%)

$400,576,000 (-22.46%)

$516,598,000 (60.95%)

$320,966,000 (-32.03%)

Investments Non-Current

$32,014,000 (-34.00%)

$48,507,000 (-57.84%)

$115,041,000 (-65.20%)

$330,532,000 (102.23%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$12,966,000 (169.17%)

$4,817,000 (22.98%)

$3,917,000 (22.14%)

$3,207,000 (-65.87%)

Accumulated Retained Earnings (Deficit)

-$1,345,106,000 (-34.23%)

-$1,002,112,000 (-30.57%)

-$767,480,000 (-31.34%)

-$584,362,000 (-74.88%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$50,994,000 (-10.37%)

$56,894,000 (-9.93%)

$63,168,000 (-5.22%)

$66,650,000 (30.80%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$50,994,000 (-10.37%)

$56,894,000 (-9.93%)

$63,168,000 (-5.22%)

$66,650,000 (30.80%)

Total Liabilities

$108,035,000 (13.63%)

$95,077,000 (-8.85%)

$104,309,000 (-47.22%)

$197,619,000 (4.10%)

Liabilities Current

$53,788,000 (55.82%)

$34,519,000 (-6.78%)

$37,028,000 (-20.78%)

$46,738,000 (-5.17%)

Liabilities Non-Current

$54,247,000 (-10.42%)

$60,558,000 (-9.99%)

$67,281,000 (-55.41%)

$150,881,000 (7.35%)

LYEL Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$61,000 (-53.08%)

$130,000 (-99.85%)

$84,683,000 (695.15%)

$10,650,000 (37.31%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$52,041,000 (-22.31%)

$66,983,000 (-42.90%)

$117,307,000 (31.72%)

$89,057,000 (89.96%)

Research & Development Expense

$171,603,000 (-6.20%)

$182,945,000 (14.92%)

$159,188,000 (14.78%)

$138,693,000 (-23.90%)

Operating Expenses

$358,816,000 (45.19%)

$247,138,000 (-9.05%)

$271,741,000 (20.55%)

$225,426,000 (2.61%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$342,994,000 (-46.18%)

-$234,632,000 (-28.13%)

-$183,118,000 (26.82%)

-$250,219,000 (-22.37%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$342,994,000 (-46.18%)

-$234,632,000 (-28.13%)

-$183,118,000 (26.82%)

-$250,219,000 (-22.37%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$342,994,000 (-46.18%)

-$234,632,000 (-28.13%)

-$183,118,000 (26.82%)

-$250,219,000 (-20.27%)

Weighted Average Shares

$261,480,000 (4.18%)

$250,983,000 (1.58%)

$247,080,000 (81.79%)

$135,918,000 (925.18%)

Weighted Average Shares Diluted

$261,480,000 (4.18%)

$250,983,000 (1.58%)

$247,080,000 (81.79%)

$135,918,000 (925.18%)

Earning Before Interest & Taxes (EBIT)

-$342,994,000 (-46.18%)

-$234,632,000 (-28.13%)

-$183,118,000 (26.82%)

-$250,219,000 (-22.37%)

Gross Profit

$61,000 (-53.08%)

$130,000 (-99.85%)

$84,683,000 (695.15%)

$10,650,000 (37.31%)

Operating Income

-$358,755,000 (-45.24%)

-$247,008,000 (-32.05%)

-$187,058,000 (12.91%)

-$214,776,000 (-1.34%)

LYEL Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$122,424,000 (-33.48%)

$184,048,000 (1694.87%)

-$11,540,000 (90.51%)

-$121,573,000 (55.55%)

Net Cash Flow from Financing

$1,326,000 (-23.92%)

$1,743,000 (-83.61%)

$10,635,000 (-97.35%)

$401,244,000 (-15.84%)

Net Cash Flow from Operations

-$162,394,000 (0.79%)

-$163,694,000 (3.46%)

-$169,555,000 (-34.30%)

-$126,249,000 (21.52%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$38,644,000 (-274.88%)

$22,097,000 (112.96%)

-$170,460,000 (-211.11%)

$153,422,000 (261.84%)

Net Cash Flow - Business Acquisitions and Disposals

-$31,346,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$154,234,000 (-17.40%)

$186,734,000 (1366.19%)

$12,736,000 (122.71%)

-$56,069,000 (74.75%)

Capital Expenditure

-$464,000 (82.73%)

-$2,686,000 (88.94%)

-$24,276,000 (62.94%)

-$65,504,000 (-27.24%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$1,402,000 (-36.27%)

$2,200,000 (-80.17%)

$11,096,000 (-97.23%)

$401,244,000 (3609.53%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$33,144,000 (-29.61%)

$47,084,000 (-42.53%)

$81,924,000 (31.71%)

$62,201,000 (87.01%)

Depreciation Amortization & Accretion

$19,631,000 (-3.06%)

$20,250,000 (12.38%)

$18,020,000 (32.27%)

$13,624,000 (217.28%)

LYEL Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-562285.20% (-211.54%)

-180486.20% (-83381.13%)

-216.20% (90.80%)

-2349.50% (12.41%)

EBITDA Margin

-530103.30% (-221.45%)

-164909.20% (-84468.82%)

-195.00% (91.22%)

-2221.50% (13.93%)

Return on Average Equity (ROAE)

-65.90% (-101.53%)

-32.70% (-52.09%)

-21.50% (44.01%)

-38.40% (-137.25%)

Return on Average Assets (ROAA)

-55.80% (-93.75%)

-28.80% (-57.38%)

-18.30% (19.03%)

-22.60% (20.42%)

Return on Sales (ROS)

-562285.20% (-211.54%)

-180486.20% (-83381.13%)

-216.20% (90.80%)

-2349.50% (10.88%)

Return on Invested Capital (ROIC)

-66.90% (-85.32%)

-36.10% (-68.69%)

-21.40% (36.69%)

-33.80% (-1.81%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.49 (76.56%)

-2.09 (55.51%)

-4.69 (-11.46%)

-4.21

Price to Sales Ratio (P/S)

2,743.37 (-26.75%)

3,745.46 (36895.88%)

10.12 (-89.75%)

98.78

Price to Book Ratio (P/B)

0.47 (-37.40%)

0.75 (-28.13%)

1.04 (-48.15%)

2

Debt to Equity Ratio (D/E)

0.28 (94.48%)

0.14 (16.00%)

0.13 (-41.31%)

0.21 (132.82%)

Earnings Per Share (EPS)

-1.31 (-40.86%)

-0.93 (-25.68%)

-0.74 (59.78%)

-1.84 (88.27%)

Sales Per Share (SPS)

0 (0%)

0 (-99.71%)

0.34 (339.74%)

0.08 (-86.67%)

Free Cash Flow Per Share (FCFPS)

-0.62 (6.03%)

-0.66 (15.43%)

-0.78 (44.44%)

-1.41 (91.19%)

Book Value Per Share (BVPS)

1.46 (-43.91%)

2.61 (-22.60%)

3.37 (-50.71%)

6.84 (131.01%)

Tangible Assets Book Value Per Share (TABVPS)

1.88 (-37.18%)

2.99 (-21.26%)

3.79 (-54.25%)

8.29 (-87.89%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-1 (75.00%)

-4 (33.33%)

-6

Enterprise Value Over EBITDA (EV/EBITDA)

-0.4 (67.02%)

-1.22 (75.31%)

-4.93 (23.97%)

-6.48

Asset Turnover

0 (0%)

0 (0%)

0.09 (750.00%)

0.01 (-9.09%)

Current Ratio

7.06 (-56.08%)

16.07 (-8.64%)

17.59 (31.26%)

13.4 (6.94%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$162,858,000 (2.12%)

-$166,380,000 (14.16%)

-$193,831,000 (-1.08%)

-$191,753,000 (9.70%)

Enterprise Value (EV)

$129,555,193 (-50.31%)

$260,704,798 (-67.94%)

$813,205,926 (-46.95%)

$1,532,963,387

Earnings Before Tax (EBT)

-$342,994,000 (-46.18%)

-$234,632,000 (-28.13%)

-$183,118,000 (26.82%)

-$250,219,000 (-22.37%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$323,363,000 (-50.83%)

-$214,382,000 (-29.85%)

-$165,098,000 (30.22%)

-$236,595,000 (-18.19%)

Invested Capital

$380,778,000 (-39.22%)

$626,473,000 (-25.41%)

$839,867,000 (-1.54%)

$853,024,000 (10.91%)

Working Capital

$325,806,000 (-37.37%)

$520,167,000 (-15.32%)

$614,267,000 (5.99%)

$579,548,000 (1.99%)

Tangible Asset Value

$490,859,000 (-34.55%)

$750,029,000 (-20.00%)

$937,561,000 (-16.84%)

$1,127,406,000 (24.13%)

Market Capitalization

$178,701,193 (-63.43%)

$488,625,798 (-43.52%)

$865,159,926 (-53.52%)

$1,861,249,387

Average Equity

$520,794,750 (-27.50%)

$718,301,500 (-15.56%)

$850,642,250 (30.66%)

$651,042,000 (422.59%)

Average Assets

$614,609,000 (-24.61%)

$815,205,500 (-18.65%)

$1,002,151,750 (-9.57%)

$1,108,199,000 (51.40%)

Invested Capital Average

$512,825,000 (-21.01%)

$649,195,000 (-24.09%)

$855,263,000 (15.58%)

$739,964,000 (20.19%)

Shares

279,220,614 (10.86%)

251,868,968 (1.02%)

249,325,627 (3.68%)

240,471,497 (-0.97%)